Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Ward

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Urologic Oncology|November 27, 2022
Robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: A multicenter collaborative studyAlireza Ghoreifi, Anirban P Mitra, George McClintock, et al.
European Urology|May 29, 2016
Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular CancerShane M Pearce, Shay Golan, Michael A Gorin, et al.
Cancers|March 10, 2022
Very Late Recurrence in Germ Cell Tumor of the Testis: Lessons and ImplicationsJoseph A Moore, Rebecca S Slack, Michael J Lehner, et al.
World Journal of Urology|January 3, 2021
Making a case "for" focal therapy of the prostate in intermediate risk prostate cancer: current perspective and ongoing trialsAlex Z Wang, Amir H Lebastchi, Luke P O'Connor, et al.
Journal of Clinical Medicine|June 27, 2024
Germ Cell Tumor of the Testis: Lethal Subtypes of a Curable CancerJamaal C Jackson, Darren Sanchez, Andrew C Johns, et al.
BJUI Compass|December 26, 2022
Predictive capacity of a miRNA panel in identifying teratoma in post-chemotherapy consolidation surgeriesJoseph A Moore, Michael J Lehner, Simone Anfossi, et al.
Cells|May 13, 2025
Bilateral Germ Cell Tumor of the Testis: Biological and Clinical Implications for a Stem Versus Genetic Origin of CancersJamaal C Jackson, Darren Sanchez, Aron Y Joon, et al.
BJU International|July 16, 2017
Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancerSpyridon P Basourakos, John W Davis, Brian F Chapin, et al.
Urology|January 4, 2020
Determining Clinically Based Factors Associated With Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance CohortJustin R Gregg, John W Davis, Chad Reichard, et al.
Cancers|February 10, 2024
A Novel Polymer-Encapsulated Multi-Imaging Modality Fiducial Marker with Positive Signal Contrast for Image-Guided Radiation TherapyLi Wang, Jeremiah Sanders, John F Ward, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Urologic Oncology|November 27, 2022
Robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: A multicenter collaborative studyAlireza Ghoreifi, Anirban P Mitra, George McClintock, et al.
European Urology|May 29, 2016
Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular CancerShane M Pearce, Shay Golan, Michael A Gorin, et al.
Cancers|March 10, 2022
Very Late Recurrence in Germ Cell Tumor of the Testis: Lessons and ImplicationsJoseph A Moore, Rebecca S Slack, Michael J Lehner, et al.
World Journal of Urology|January 3, 2021
Making a case "for" focal therapy of the prostate in intermediate risk prostate cancer: current perspective and ongoing trialsAlex Z Wang, Amir H Lebastchi, Luke P O'Connor, et al.
Journal of Clinical Medicine|June 27, 2024
Germ Cell Tumor of the Testis: Lethal Subtypes of a Curable CancerJamaal C Jackson, Darren Sanchez, Andrew C Johns, et al.
BJUI Compass|December 26, 2022
Predictive capacity of a miRNA panel in identifying teratoma in post-chemotherapy consolidation surgeriesJoseph A Moore, Michael J Lehner, Simone Anfossi, et al.
Cells|May 13, 2025
Bilateral Germ Cell Tumor of the Testis: Biological and Clinical Implications for a Stem Versus Genetic Origin of CancersJamaal C Jackson, Darren Sanchez, Aron Y Joon, et al.
BJU International|July 16, 2017
Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancerSpyridon P Basourakos, John W Davis, Brian F Chapin, et al.
Urology|January 4, 2020
Determining Clinically Based Factors Associated With Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance CohortJustin R Gregg, John W Davis, Chad Reichard, et al.
Cancers|February 10, 2024
A Novel Polymer-Encapsulated Multi-Imaging Modality Fiducial Marker with Positive Signal Contrast for Image-Guided Radiation TherapyLi Wang, Jeremiah Sanders, John F Ward, et al.
Pageof 11